Tanzania aims to double domestic drug production

18 June 2012

Local pharma manufacturers in Tanzania have targeted increasing production capacity by 50% by 2015 hoping to reduce importation of medicines currently standing at more than 70%, reports the Tanzania Daily News.

The move is part of the strategies envisaged by the Federation of East African Pharmaceutical Manufacturers which was formed last year. The upshot is to make sure the country and counterparts in the East African region produce sufficient medicines.

Speaking to the Daily News at the weekend, Federation chairman and managing director of local drugmaker Tanzania Pharmaceutical Industries Ramadhani Madabida said that shortage of human medicines in the country was a major issue that needed to be jointly tackled by all stakeholders. “With the exception of Tanzania and Kenya, where manufacturers can produce at least 30% of the total local needs, the situation was even worse in other member states and it is high time we struggled to come out of this situation,” he said.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Today's issue

Company Spotlight





More Features in Generics